SCHEMBL8916607

SCHEMBL8916607

CC(=O)c1cccnc1NC(C)c1c(Cl)cccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
GAA P10253 4/20 0.42
ALDH1A1 P00352 2/20 0.42
TOP1 P11387 1/20 0.42
MT-CO2 P00403 1/20 0.39
CLCN2 P51788 1/20 0.39
MAPT P10636 2/20 0.39
PIK3CB P42338 1/20 0.39
GRM4 Q14833 1/20 0.38
KDR P35968 1/20 0.38
PABPC1 P11940 1/20 0.37
EIF4H Q15056 1/20 0.37
AGTR1 P30556 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8917175 0.82 DHODH (0.38) DHODHMEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL8790511 0.77 CYP1A2 (0.42) MEN1KMT2ASMN1; SMN2ALDH1A1MT-CO2
SCHEMBL8918547 0.75 MEN1 (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1RAB9A
SCHEMBL8918710 0.74 HPGD (0.64) SMN1; SMN2L3MBTL1RAB9ANPC1GAA
SCHEMBL12990441 0.71 KMT2A (0.46) DHODHMEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL16388912 0.69 DHODH (0.47) DHODHMEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL19791389 0.69 RAB9A (0.43) DHODHMEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL16414490 0.69 ALDH1A1 (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1RAB9A
SCHEMBL16616388 0.69 RAB9A (0.76) DHODHMEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL16616153 0.69 MEN1 (0.62) DHODHMEN1KMT2ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5480997-A VIRICIDE FOR HIV JANSSEN PHARMACEUTICA N.V. (BE) 1996-01-02 US claimed
US-5604230-A USEFUL IN INHIBITING THE REPLICATION OF HIV JANSSEN PHARMACEUTICA N.V. (BE) 1997-02-18 US disclosed
US-5587387-A ANTIRETROVIRAL COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 1996-12-24 US disclosed
US-5552430-A ANTIRETROVIRAL COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 1996-09-03 US disclosed
US-5550135-A ANTIRETROVIRAL AGENTS; TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 1996-08-27 US disclosed
US-5541215-A ANTIRETROVIRAL COMPOUNDS; TREATING HIV INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 1996-07-30 US disclosed
US-5480997-A VIRICIDE FOR HIV JANSSEN PHARMACEUTICA N.V. (BE) 1996-01-02 US disclosed
EP-0620811-A1 HETEROCYCLE-SUBSTITUTED BENZYLAMINE DERIVATIVES AS ANTIRETROVIRAL COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 1994-10-26 EP disclosed
WO-1993013069-A1 HETEROCYCLE-SUBSTITUTED BENZYLAMINE DERIVATIVES AS ANTIRETROVIRAL COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 1993-07-08 WO disclosed